THE BOTTOM LINE GLP-1 medications have opened exciting new possibilities for weight-loss, but they shouldnt replace movement they should complement it
Retatrutide Contraindications (Anticipated) Retatrutide may be contraindicated in individuals with: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Known hypersensitivity to formulation components History of pancreatitis (use with caution
Canada has a higher availability of Ozempic compared to the US, ensuring a more reliable supply
Suzanne Nielsen, Joo Pedro Silva, Jermaine D
Thomas George, M.D., FACP, FASCO, was interviewed by AAMC News on how GLP-1 medications affect cancer risk and mortality
Accurate address data is required for mail notifications and jurisdictional handling (e.g., Quebec routing)